Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:975 (3 May), doi:10.1136/bmj.39563.588762.BE
| The first 150 words of the full text of this article appear below. |
Chokshi and Kesselheim make a strong case for developing countries to invest in an evidence base for developing and appropriately using newer vaccines.1 However, an infrastructure of the required research and information systems is entirely absent in developing countries and its creation would require the complete revamping of current public health systems. Those who promote vaccines as the most cost effective interventions for poor people never take into account the costs of erecting the health systems to deliver them and monitor their efficacy and safety.
The authors quote Amartya Sen to show the opportunities that open up for poor people in developing countries from modern health systems with delivery of vaccines. However, these people have competing needs for food, shelter, water, sanitation, and education. In reality, vaccines compete with these other needs. One example is that the widely prevalent malnutrition in children in India results from lack of health education
Onkar Mittal, national convener
1 Centre for Health Policy Dialogue, New Delhi 110049, India
o_mittal@rediffmail.com